Varda Barmatz-Shoshan
Beersheba, D 84105, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
MAVS as a Key Regulator of Tumor Proliferation, Survival, the Tumor Microenvironment, and Immunity.
Journal: Biomolecules
Published: February 18, 2026
Erratum: Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects.
Journal: Molecular therapy. Oncology
Published: February 09, 2026
Targeting ST18-mediated pathomechanism in pemphigus vulgaris through voltage-dependent anion channel inhibition.
Journal: Skin health and disease
Published: October 30, 2025
Targeting VDAC1 to protect against mitochondria-linked cell death pathways: apoptosis, pyroptosis, ferroptosis, and associated diseases.
Journal: Apoptosis : an international journal on programmed cell death
Published: September 03, 2025
Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects.
Journal: Molecular therapy. Oncology
Published: July 30, 2025
Resveratrol's Pro-Apoptotic Effects in Cancer Are Mediated Through the Interaction and Oligomerization of the Mitochondrial VDAC1.
Journal: International journal of molecular sciences
Published: March 23, 2025
Metformin-Induced Apoptosis Is Mediated Through Mitochondrial VDAC1.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 04, 2025
Decoding Cancer through Silencing the Mitochondrial Gatekeeper VDAC1.
Journal: Biomolecules
Published: August 26, 2024
Etoposide-induced cancer cell death: roles of mitochondrial VDAC1 and calpain, and resistance mechanisms.
Journal: Molecular oncology
Published: August 13, 2024
VDAC1-Based Peptides as Potential Modulators of VDAC1 Interactions with Its Partners and as a Therapeutic for Cancer, NASH, and Diabetes.
Journal: Biomolecules
Published: July 25, 2024
Last Updated: 09/26/2026